Flowers financial looking to bloom through Ipac partnership
Flowers Financial Group has entered into a strategic alliance with Ipac Securities with a view to growing the financial planning arm of its business.
To date, the cornerstone of Flowers’ business has been to position itself among those people in the medical profession in order to service their financial advisory needs.
The group’s financial planning area currently has five advisers, and the business is responsible for $200 million in funds under management.
Flowers has aligned itself with Ipac specifically to take advantage of the firm’s solid track record in building relationships and providing advice to senior executives, which was seen as a good fit with its own medical client base.
Flowers executive chairman Nigel Flowers said: “Many of our early clients are now well established and require a broader range of financial planning services. By partnering with Ipac, we can streamline the way we deliver these services and further enhance our offer.”
Ipac business partnering director Suvan de Soysa said Flowers’ decision to form an association with his organisation was a more logical decision than trying to consolidate their niche offering alone.
“Flowers has a well developed business model in this market segment. We can help them grow by using our advice model, tools and practice management support. In return, we can see how they deliver to the unique needs of these clients. This knowledge can be shared across our adviser community,” Soysa said.
Recommended for you
Clime’s disposal of advice licensee Madison “needed to happen yesterday”, managing director Michael Baragwanath has told Money Management, as he concludes a severe cost-out period at the business.
As Viola Private Wealth continues on its growth trajectory, the wealth management firm has appointed a seasoned investment professional to be its first chief investment officer.
Financial advisers who wish to implement artificial intelligence in their practices need to undergo a change in their mindset as to how they use technology.
With United Global Capital expected to constitute a substantial portion of CSLR compensation in FY25–26, what has AFCA ruled in its determinations on the company so far?